These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29976766)

  • 21. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition.
    Coetzee GA; Strachan AF; van der Westhuyzen DR; Hoppe HC; Jeenah MS; de Beer FC
    J Biol Chem; 1986 Jul; 261(21):9644-51. PubMed ID: 3525531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice.
    Hosoai H; Webb NR; Glick JM; Tietge UJ; Purdom MS; de Beer FC; Rader DJ
    J Lipid Res; 1999 Apr; 40(4):648-53. PubMed ID: 10191288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of serum amyloid A on high density lipoprotein composition and levels.
    de Beer MC; Webb NR; Wroblewski JM; Noffsinger VP; Rateri DL; Ji A; van der Westhuyzen DR; de Beer FC
    J Lipid Res; 2010 Nov; 51(11):3117-25. PubMed ID: 20667817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.
    Wilson PG; Thompson JC; Webb NR; de Beer FC; King VL; Tannock LR
    Am J Pathol; 2008 Dec; 173(6):1902-10. PubMed ID: 18974302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum amyloid A protein generates pre beta 1 high-density lipoprotein from alpha-migrating high-density lipoprotein.
    Miida T; Yamada T; Yamadera T; Ozaki K; Inano K; Okada M
    Biochemistry; 1999 Dec; 38(51):16958-62. PubMed ID: 10606531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient mice.
    De Beer MC; Wroblewski JM; Noffsinger VP; Rateri DL; Howatt DA; Balakrishnan A; Ji A; Shridas P; Thompson JC; van der Westhuyzen DR; Tannock LR; Daugherty A; Webb NR; De Beer FC
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):255-61. PubMed ID: 24265416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of serum amyloid A on cellular cholesterol efflux to serum in type 2 diabetes mellitus.
    Tsun JG; Shiu SW; Wong Y; Yung S; Chan TM; Tan KC
    Atherosclerosis; 2013 Dec; 231(2):405-10. PubMed ID: 24267259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A brief elevation of serum amyloid A is sufficient to increase atherosclerosis.
    Thompson JC; Jayne C; Thompson J; Wilson PG; Yoder MH; Webb N; Tannock LR
    J Lipid Res; 2015 Feb; 56(2):286-93. PubMed ID: 25429103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycystic ovary syndrome influences the level of serum amyloid A and activity of phospholipid transfer protein in HDL₂ and HDL₃.
    Gidwani S; Phelan N; McGill J; McGowan A; O'Connor A; Young IS; Gibney J; McEneny J
    Hum Reprod; 2014 Jul; 29(7):1518-25. PubMed ID: 24842896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake.
    Cai L; de Beer MC; de Beer FC; van der Westhuyzen DR
    J Biol Chem; 2005 Jan; 280(4):2954-61. PubMed ID: 15561721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretion of serum amyloid protein and assembly of serum amyloid protein-rich high density lipoprotein in primary mouse hepatocyte culture.
    Hoffman JS; Benditt EP
    J Biol Chem; 1982 Sep; 257(17):10518-22. PubMed ID: 6809750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities.
    Mero N; Van Tol A; Scheek LM; Van Gent T; Labeur C; Rosseneu M; Taskinen MR
    J Lipid Res; 1998 Jul; 39(7):1493-502. PubMed ID: 9684753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum amyloid A is independently related to apolipoprotein A-I but not to HDL-cholesterol in patients with angina pectoris.
    Korita I; Bulo A; Langlois MR; Verhoye E; Blaton V
    Clin Biochem; 2013 Nov; 46(16-17):1660-3. PubMed ID: 23994331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the binding and endocytosis of high-density lipoprotein from healthy (HDL) and inflamed (HDL(SAA)) donors by murine macrophages of four different mouse strains.
    Röcken C; Kisilevsky R
    Virchows Arch; 1998 Jun; 432(6):547-55. PubMed ID: 9672197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice.
    Lewis KE; Kirk EA; McDonald TO; Wang S; Wight TN; O'Brien KD; Chait A
    Circulation; 2004 Aug; 110(5):540-5. PubMed ID: 15277327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural studies of a serum amyloid A octamer that is primed to scaffold lipid nanodiscs.
    Nady A; Reichheld SE; Sharpe S
    Protein Sci; 2024 May; 33(5):e4983. PubMed ID: 38659173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin interactions with apoA1 and SAA in inflammation-associated HDL.
    Digre A; Nan J; Frank M; Li JP
    Biochem Biophys Res Commun; 2016 May; 474(2):309-314. PubMed ID: 27105909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein.
    Sato M; Ohkawa R; Yoshimoto A; Yano K; Ichimura N; Nishimori M; Okubo S; Yatomi Y; Tozuka M
    Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27422844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced apolipoprotein glycosylation in patients with the metabolic syndrome.
    Savinova OV; Fillaus K; Jing L; Harris WS; Shearer GC
    PLoS One; 2014; 9(8):e104833. PubMed ID: 25118169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.